印度尼西亚雅加达输血后乙型肝炎风险评估。
Estimate of the risk of post transfusion hepatitis B in Jakarta, Indonesia.
作者信息
Mboi N, Olson J G, McGreevy P B, Tan R, Moeslichan S
出版信息
Int J Epidemiol. 1981 Dec;10(4):367-72. doi: 10.1093/ije/10.4.367.
The prevalences of hepatitis B surface antigen (HBsAg) and antibody to HBsAg (anti-HBs) were determined in blood donors and transfusion recipients in Jakarta, Indonesia. In blood donors the prevalence of HBsAg was 10% while anti-HBs was 43%. In transfusion recipients the prevalence of HBsAg and anti-HBs was 67%. The prevalence of susceptible recipients or those without detectable HBsAg or anti-HBs was 33%. Thus, the probability that a susceptible recipient would receive HBsAg from a blood donor was calculated at 3.3%. Published data from other studies were used to estimate the risk of clinical post transfusion hepatitis in Jakarta at between 0% and 2%.
在印度尼西亚雅加达的献血者和输血接受者中测定了乙肝表面抗原（HBsAg）和乙肝表面抗原抗体（抗-HBs）的流行率。在献血者中，HBsAg的流行率为10%，而抗-HBs为43%。在输血接受者中，HBsAg和抗-HBs的流行率为67%。易感接受者或那些未检测到HBsAg或抗-HBs的人的流行率为33%。因此，计算得出易感接受者从献血者那里获得HBsAg的概率为3.3%。来自其他研究的已发表数据被用于估计雅加达临床输血后肝炎的风险在0%至2%之间。
Zotero 插件